Literature DB >> 7713185

Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development.

A Schuchat1, J D Wenger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7713185     DOI： 10.1093/oxfordjournals.epirev.a036159

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN： 0193-936X            Impact factor:   6.222


× No keyword cloud information.
  45 in total

1.  Inhibition enzyme-linked immunosorbent assay for serotyping of group B streptococcal isolates.

Authors:  G Arakere; A E Flores; P Ferrieri; C E Frasch
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

2.  Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions.

Authors:  H D Davies; C E Adair; A Schuchat; D E Low; R S Sauve; A McGeer
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

3.  Prevalence of group B streptococcal type VI capsular IgG antibodies in Japan.

Authors:  K Matsubara; K Katayama; K Baba; H Nigami; H Harigaya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-24       Impact factor: 3.267

4.  Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Authors:  Ravin Seepersaud; Sean B Hanniffy; Peter Mayne; Phil Sizer; Richard Le Page; Jerry M Wells
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention.

Authors:  M Trijbels-Smeulders; G A de Jonge; P C M Pasker-de Jong; L J Gerards; A H Adriaanse; R A van Lingen; L A A Kollée
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01-16       Impact factor: 5.747

6.  Characterization of a small mobilizable transposon, MTnSag1, in Streptococcus agalactiae.

Authors:  Adeline Achard; Roland Leclercq
Journal:  J Bacteriol       Date:  2007-04-06       Impact factor: 3.490

7.  Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1.

Authors:  Francesco Doro; Sabrina Liberatori; Manuel J Rodríguez-Ortega; Cira D Rinaudo; Roberto Rosini; Marirosa Mora; Maria Scarselli; Emrah Altindis; Romina D'Aurizio; Maria Stella; Immaculada Margarit; Domenico Maione; John L Telford; Nathalie Norais; Guido Grandi
Journal:  Mol Cell Proteomics       Date:  2009-04-28       Impact factor: 5.911

8.  Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

Authors:  M Fernandez; M E Hickman; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

9.  Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity.

Authors:  Sheng-Mei Jiang; Nadeeza Ishmael; Julie Dunning Hotopp; Manuela Puliti; Luciana Tissi; Nikhil Kumar; Michael J Cieslewicz; Hervé Tettelin; Michael R Wessels
Journal:  J Bacteriol       Date:  2008-01-18       Impact factor: 3.490

10.  Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae.

Authors:  Herve Tettelin; Vega Masignani; Michael J Cieslewicz; Jonathan A Eisen; Scott Peterson; Michael R Wessels; Ian T Paulsen; Karen E Nelson; Immaculada Margarit; Timothy D Read; Lawrence C Madoff; Alex M Wolf; Maureen J Beanan; Lauren M Brinkac; Sean C Daugherty; Robert T DeBoy; A Scott Durkin; James F Kolonay; Ramana Madupu; Matthew R Lewis; Diana Radune; Nadezhda B Fedorova; David Scanlan; Hoda Khouri; Stephanie Mulligan; Heather A Carty; Robin T Cline; Susan E Van Aken; John Gill; Maria Scarselli; Marirosa Mora; Emilia T Iacobini; Cecilia Brettoni; Giuliano Galli; Massimo Mariani; Filippo Vegni; Domenico Maione; Daniela Rinaudo; Rino Rappuoli; John L Telford; Dennis L Kasper; Guido Grandi; Claire M Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-28       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.